Is There a Decreased Duration of Acute Urinary and Bowel Symptoms after Prostate Brachytherapy with Cesium 131 Isotope?

Cancer types prostate


DeFoe SG, et al.

International Journal of Radiation Oncology Biology Physics
September 1, 2008
Dr. DeFoe, from the University of Pittsburgh, reports on a series of 94 patients treated with Cesium-131 prostate brachytherapy. In agreement with other, similar, studies, the Cesium treated patients overcome brachytherapy-related urinary symptoms within six months. Their data suggests an early cessation of urinary side effects because of the short half-life of Cesium-131.

Related posts

Early Outcomes of Prostate Seed Implants with 131Cs: Toxicity and Initial PSA Dynamics from a Single Institution

Authors: C.S. Platta, D. Khuntia, J. Adkinson, E. Olson, S. Jennifer, H. Odau, R.R. Patel

Long-Term Quality of Life in Prostate Cancer Patients Treated With Cesium-131

Authors: Glaser SM, Chen KS, Benoit RM, Smith RP, Beriwal S.

Is Cs-131 or I-125 or Pd-103 the “Ideal” Isotope for Prostate Boost Brachytherapy?–A Dosimetric View Point

Authors: R. Yaparpalvi, J. Rossinow, W.A. Cavanagh, W. Choi, L. Minsky, N. Kahan, W. Bodner, M. Garg, S. Kalnicki, C. Guha

Scroll to top